Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma

Lignende værker

• Treating Japanese Patients With Pembrolizumab for Platinum-Refractory Advanced Urothelial Carcinoma in Real-World Clinical Practice
  af: Furubayashi, Nobuki, et al.
  Udgivet: (2020)
• Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy
  af: Furubayashi, Nobuki, et al.
  Udgivet: (2021)
• Organ-Specific Therapeutic Effect of Paclitaxel and Carboplatin Chemotherapy After Platinum-Based Chemotherapy and Pembrolizumab for Metastatic Urothelial Carcinoma
  af: Furubayashi, Nobuki, et al.
  Udgivet: (2020)
• The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy
  af: Furubayashi, Nobuki, et al.
  Udgivet: (2017)
• Timing of changing therapy from gemcitabine and cisplatin chemotherapy based on real-world data of advanced urothelial carcinoma
  af: Furubayashi, Nobuki, et al.
  Udgivet: (2020)